To include your compound in the COVID-19 Resource Center, submit it here.

FDA approves first biosimilar for cancer

FDA approved a BLA from Amgen Inc. (NASDAQ:AMGN) for Mvasi bevacizumab-awwb (ABP 215), a

Read the full 140 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE